Cornely, O A., & Heußel, C P. (2014). A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial). Blood, 124, .

"A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) / Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget" Blood .

Cornely, Oliver Andreas, and Claus Peter Heußel. "A Double-blind,multicentre, Randomised, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of Prophylactic Liposomal Amphotericin B (AmBisome (R)) for the Prevention of Invasive Fungal Infections in Subjects Receiving Remission-induction Chemotherapy for Acute Lymphoblastic Leukaemia (AmBiGuard Trial)." Blood 124 (2014).